An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors

Autor: Abdelbaki, Mohamed S., DeWire Schottmiller, Mariko Dawn, Cripe, Timothy P., Curry, Richard C., Cruze, Charles A., Her, Leah, Demko, Suzanne, Casey, Denise, Setty, Bhuvana
Zdroj: In Heliyon December 2022 8(12)
Databáze: ScienceDirect